LONDON, 25 May, 2010 – Panmure Gordon & Co. is pleased to announce its appointment as nominated adviser and broker to e-Therapeutics plc with immediate effect.

e-Therapeutics is a drug discovery and development company that has developed proprietary computational systems to analyse and predict how medicines interact with cells in the body.

Welcoming e-Therapeutics as a client, Panmure Gordon group chief executive, Tim Linacre said: “We are delighted to have attracted e-Therapeutics plc as a client. It is a company with a very compelling business story. We look forward to working with the e-Therapeutics board, and developing a long-term relationship that is the hallmark of our service to all our clients.”